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ABSTRACT

27
Host interferon-induced transmembrane proteins (IFITMs) are broad-spectrum antiviral restriction 28 factors. Of these, IFITM3 potently inhibits viruses that enter cells through acidic endosomes, many 29 of which are zoonotic and emerging viruses with bats (order Chiroptera) as natural hosts. We 30 previously demonstrated that microbat IFITM3 is antiviral. Here we show that bat IFITMs are 31 characterized by strong adaptive evolution and identify a highly variable and functionally important 32 site -codon 70 -within the conserved CD225 domain of IFITMs. Mutation of this residue in microbat 33 IFITM3 impairs restriction of four different virus families that enter cells via endosomes. This mutant 34 shows altered subcellular localization and reduced S-palmitoylation, a phenotype copied by 35 mutation of conserved cysteine residues in microbat IFITM3. Furthermore, we show that microbat 36 IFITM3 is S-palmitoylated on cysteine residues C71, C72 and C105, mutation of each cysteine 37 residue individually impairs virus restriction, and a triple C71-C72-C105 mutant loses all restriction, 38 concomitant with subcellular re-localization of microbat IFITM3 to Golgi-associated sites. Thus, we 39 propose that S-palmitoylation is critical for Chiropteran IFITM3 function and identify a key although there is evidence that other IFITM topologies exist [6] [7] [8] . The results of spectroscopic 60 topological studies agree with the Type II transmembrane configuration, as do bioinformatic 61 predictions of IFITM3 secondary structure that reveal three alpha helices, with the C-terminal helix 62 forming a single transmembrane domain [9, 10] . The CD225 domain is highly conserved among 63 IFITMs and comprises an intramembrane domain (IMD) and CIL domain. The hydrophobic IMD 64 contains a 10-residue amphipathic helix (amino acid residues 59-68 of human IFITM3) that is 36] and in humans single nucleotide polymorphisms in IFITM3, that may act by altering IFITM3 111 expression or subcellular distribution, have been associated with an increase in morbidity in IAV and 112 HIV-1 infections (recently reviewed by [37, 38] ). Antiviral function has also been reported for IFITMs 113 from diverse mammalian and avian species [39] [40] [41] [42] [43] [44] , although little is known about the role of IFITMs 114 in antiviral defense in these species and in shaping host range. Phylogenetic studies have shown 115 that the IFITM gene family is evolutionarily conserved and characterized by gene duplication, copy 116 number variation and the presence of pseudogenes [2, 45] . Whereas humans possess a single IFITM3 117 gene, a remarkable multiplicity of IFITM3-like genes exists in the genomes of some other primates; 118 for example, there are 25 IFITM3-like variants in the marmoset and eight in the African green 119 monkey [2, 46] . Interestingly, several of these variants contain N-terminal polymorphisms which, 120 when inserted into human IFITM3, prevent ubiquitination and endocytosis, however the function of 121 these duplicated IFITM3-like genes has not been tested [46] .
123
The antiviral responses of bats (mammalian order Chiroptera) are of particular interest because 124 these animals have been increasingly recognized as reservoir hosts from which numerous viruses 125 have ultimately emerged, with severe pathogenic and socioeconomic consequences in humans and 126 livestock. Indeed, a recent analysis showed that bats host a significantly higher proportion of 127 zoonotic viruses than all other mammalian orders [47] . Moreover, Chiroptera are the only order that 128 harbor significantly more zoonotic viruses than would be predicted from reporting effort and host 129 traits such as geographic range and mammal sympatry. It is possible that this propensity to be 130 reservoirs for a large number of viruses, many of which may remain asymptomatic, in part reflects 6 Phylogenetic analysis of Chiropteran IFITM genes 145 Viral restriction activity is conserved in microbat IFITM3 [39] . However, Chiropteran IFITMs have not 146 been included in previous phylogenetic analyses, even though bats comprise ~20% of all 147 mammalian species. Accordingly, we first analyzed the phylogenetic relationships of IR-IFITM gene 148 sequences from 32 eutherian mammal species including 13 species of bat. The genes analyzed were 149 identified either via tBLAST or from our cDNA analyses (rapid amplification of cDNA ends (RACE) 150 on cells from Myotis myotis, Eptesicus serotinus and Sus scrofa, and proteomics informed by 151 transcriptomics [53] for Pteropus alecto). The resulting phylogeny revealed relatively high levels of 152 sequence divergence (nucleotide substitutions per site) between the IFITM genes ( Fig. 1) . Notably, The IFITM gene family is notable for gene duplications, variation in copy number and the presence 158 of pseudogenes [2, 54] and our previous tBLAST searches identified multiple IFITM-like genes for 159 many species. In most cases, there are little data to differentiate functional from non-functional 160 IFITM-like genes. Therefore, to assess possible selection pressures, we performed phylogenetic 161 analysis on a selection of mammalian IR-IFITM genes for which there is evidence of function 162 ( Supplementary Table 1 ): this data set comprises 31 IFITMs from 17 species, including 8 Chiropteran 163 species ( Fig. 2A) . The selection pressures acting on these IFITM genes were assessed using the 164 numbers of nonsynonymous (d N ) to synonymous (d S ) nucleotide substitutions per site, with d N >d S 165 indicative of positive selection (i.e. adaptive evolution), using the adaptive Branch Site REL method 166 (aBSREF; [55] ) that is able to determine selection pressures acting on specific branches of the input 167 phylogeny. This analysis revealed that 6.8% of the codons in the sequence alignment were strongly 168 positively selected on the branch leading to all Chiropteran IFITMs, with a d N >d S of infinity (LRT = 169 14.95; p = 0.002).
171
Codon 70 is highly diverse among mammalian IFITMs
172
To visualize amino acid diversity, a logo diagram was constructed for the alignment of 31 173 'functional' IFITMs. This revealed notable amino acid diversity at codon 70, located within the 174 otherwise highly conserved CD225 domain and directly upstream of the double cysteine motif 175 C71/C72 (Fig. 2B ). The amino acids at codon 70 for the 31 functional mammalian IFITMs, as well the 176 likely ancestral codons at this site at key nodes in the phylogeny inferred using a parsimony 177 procedure, are indicated on Fig. 2A . The human IFITM3, IFITM2 and IFITM1 proteins each encode a 7 distinct amino acid at codon 70 (P, T and W, respectively). A further three amino acids occur in 179 IFITM proteins with confirmed antiviral activity: F (in mouse IFITM3 and IFITM1), A (in mouse 180 IFITM2) and G (in mouse IFITM6; not used in the phylogenetic analysis). Assessing novel IFITM3 181 sequences we obtained using RACE and RT-PCR for 4 species of microbat also highlighted codon 70 182 as the only non-conserved residue within the CD225 domain of microbat IFITM3, and it was notable 183 that two microbat species encode valine (V) at this position (Fig. 2C ).
185
We next performed a site-specific selection analysis using the phylogeny of the 31 functional IFITMs 186 shown in Fig. 2A . Using the SLAC (counting) method, codon 121, within the C-terminal IFITM 187 domain, was the only site identified as under significant positive selection (p<0.1; mean d N -d S value 188 of 2.64). Although there was no statistically significant evidence for positive selection on codon 70 189 (p = 0.192), it had the second highest d N -d S value of any site (1.91), with 14 non-synonymous 190 nucleotide changes (compared to 13.5 at codon 121) and only two synonymous changes across the 191 phylogeny. Similar results (i.e. close to significant positive selection) were obtained using the 192 FUBAR (Bayesian) method.
194
Codon 70 affects antiviral restriction by microbat IFITM3
195
To assess the functional effects of variation at codon 70, polyclonal stable A549 cells were made 196 expressing C-terminally HA-tagged wild type (wt) human IFITM3 (i.e. huIFITM3 P70) and human 197 IFITM3 encoding each of the other 6 amino acids that occur naturally in mammals at position 70 (i.e.
198
A, T, G, W, F and V). In addition, we made C-terminally HA-tagged wt microbat M. myotis IFITM3 199 (mbIFITM3) and a mbIFITM3 P70W mutant: W is a possible ancestral codon for the Laurasiatherian 200 and primate IFITM clades ( Fig. 2A ) and occurs in functional IFITMs such as pig IFITM3 and human 201 IFITM1, but not in the bat IFITMs sequenced to date.
203
The mutant IFITM3 proteins were tested for their ability to restrict cell entry by Zika Virus (ZIKV),
204
Semliki Forest Virus (SFV) and influenza A virus (IAV) (Fig. 3 ). Flow cytometry was used to 205 determine the proportion of infected cells following single cycle infection and a representative 206 experiment of three independent experiments is shown ( Fig. 3A-C) . Each of the huIFITM3 codon 70 207 mutants restricted ZIKV infectivity with similar potency as wt huIFITM3 and wt mbIFITM3 (all <4% 208 infection at an MOI of 10 and <1% infection at an MOI of 1). In contrast, mbIFITM3 P70W was 209 significantly less restrictive than wt (35% ZIKV infection at an MOI of 10 and 7% at an MOI of 1) ( Fig.   210 3A). Similarly, small variations in infectivity of both SFV ( Fig. 3B ) and IAV ( Fig. 3C) were apparent for 211 the huIFITM3 codon 70 mutants, while infectivity of both viruses was markedly higher in cells 8 expressing mbIFITM3 P70W compared to wt mbIFITM3. Expression levels of wt mbIFITM3 and 213 mbIFITM3 P70W were comparable when analyzed by western blotting (Fig. 3A, 3B , S1A) and flow 214 cytometry ( Fig. S1B ). Using multicycle IAV infection, we investigated the impact on infectious yields 215 and found that cells expressing mbIFITM3 P70W gave 8-fold greater IAV titres than cells expressing 216 wt mbIFITM3 (Fig. 3D) . Overall, the P70W substitution in mbIFITM3 significantly reduces restriction 217 of three different families of viruses that enter cells via pH-dependent fusion from endosomes. To assess the impact of P70 mutations on the subcellular localization of huIFITM3 and mbIFITM3, 221 confocal immunofluorescence imaging was performed on A549 cells stably expressing either wt or 222 P70W mutants of C-terminally HA-tagged huIFITM3 and mbIFITM3 (Fig. 4) . In fixed and 223 permeabilised cells, wt huIFITM3 and mbIFITM3 had a punctate intracellular distribution, as 224 described previously [5, 39] , and huIFITM3 P70W showed a similar localization ( Fig. 4) . In contrast, 225 mbIFITM3 P70W showed a different distribution, with prominent perinuclear Golgi-like labelling 226 ( Fig. 4A, permeabilised) . When cells were labelled in the absence of detergent ( Fig 4A, intact) , some 227 wt huIFITM3 was detected at the cell surface, as reported previously, and this was similar for 228 huIFITM3 P70W. The strong cell surface labelling seen for wt mbIFITM3 was much reduced for 229 mbIFITM3 P70W (Fig. 4A , intact), suggesting reduced trafficking to the plasma membrane. To 230 examine IFITM3 trafficking to the cell surface, cells were incubated in medium containing anti-HA 231 mAb at 37°C for 60 min prior to fixation with or without permeabilization ( Fig. 4B ) to reveal 232 internalised or cell surface anti-HA antibodies, respectively. In cells expressing huIFITM3s, similar 233 intracellular punctate labelling was observed on permeabilized cells, suggesting that equivalent 234 trafficking to the cell surface and subsequent endocytosis occurred for both wt and huIFITM3 P70W.
235
Consistent with this, similar levels of cell surface labelling were seen for both proteins on intact 236 cells. Significant intracellular labelling (permeabilized cells) and cell surface labelling (intact cells) 237 was seen on cells expressing wt mbIFITM3, but very little internal or cell surface staining was seen 238 for cells expressing mbIFITM3 P70W. Together, these data indicate that the P70W mutation in 239 mbIFITM3 significantly reduces trafficking of the protein to the cell surface and, as a consequence, 240 there is little subsequent endocytic uptake of the protein into endosomal compartments.
242
As our initial observations suggested mbIFITM3 P70W may be preferentially associated with Golgi 243 compartments ( Fig. 4A ), we co-labelled fixed and permeabilised cells with anti-HA mAb (to detect 244 the HA-tagged IFITM3 protein) and markers of intracellular organelles. Clear overlap was seen for 245 the perinuclear concentrations of mbIFITM3 P70W with the cis Golgi marker Giantin ( Fig. 4C ) and with the trans Golgi network marker TGN46 ( Fig. S2A ) whereas the huIFITM3 proteins and wt 247 mbIFITM3 showed significantly less overlap. Together, these data suggest that mbIFITM3 P70W 248 showed increased association with the Golgi apparatus and reduced trafficking to the cell surface 249 compared to the wt mbIFITM3 protein and the huIFITM3 proteins. Moreover, huIFITM3 P70W did 250 not show any obvious alteration in its trafficking properties and behaved similarly to the wt protein.
251
These properties correlated with the reduced viral restriction observed for mbIFITM3 P70W (Fig. 3) . 
278
Microbat IFITM3 is S-palmitoylated on C71, C72 and C105 S-palmitoylation of IFITMs has only previously been studied for human and mouse proteins. To 280 investigate S-palmitoylation in mbIFITM3, cysteine-to-alanine substitutions were made at 281 conserved cysteine residues (C71, C72 and C105). A549 cells stably expressing single mutants C71A, 282 C72A and C105A, the double C71A-C72A mutant and the triple C71A-C72A-C105A mutant were 283 generated. Two methods were used to assess S-palmitoylation: (i) the acyl exchange gel shift 284 method described above ( Fig. 5 and 6A ), and (ii) visualisation of palmitoylated proteins by in-gel 285 fluorescence ( Fig. 6B ). For this, cells were metabolically labelled with a 'clickable' alkyne palmitate 286 analogue followed by further modification of the palmitoylated proteins via copper-catalyzed 287 azide-alkyne cycloaddition reaction (i.e. 'click chemistry') using a TAMRA-labelled capture reagent.
288
The described metabolic labelling approach has been extensively used to successfully quantify a 289 variety of PTMs [57] [58] [59] . Comparing the two orthogonal methods (acyl exchange and metabolic 290 labelling) used in this study reveals that both approaches have different informational value. The 291 acyl exchange method only enables the quantification of the total amount of palmitoylated IFITM3.
292
Due to the multivalency of the streptavidin, multiple PTMs might still result in a 1:1 ratio of the in the case of wt huIFITM3 and wt mbIFITM3. While the TAMRA fluorescence for wt huIFITM3 was 301 greater than for wt mbIFITM3 and huIFITM3 P70W ( Fig. 6B ), the acyl exchange result did not show a 302 significant difference in the proportion of palmitoylated protein in either case ( Fig. 6A ). Hence, the 303 total amount of palmitoylated IFITM3 is equivalent in all three cases, however, the number of 304 palmitoylations per protein differs. 305 306 Importantly, the results of both methods for the different cysteine mutants of mbIFITM3 showed 307 that the single cysteine mutants (C71A, C72A and C105A) have reduced palmitoylation compared to 308 wt mbIFITM3, with a greater reduction for C72A than C71A. A double C71A-C72A mutant still 309 showed some acylation, indicating that C105 can be acylated, while the triple mutant abrogated 310 palmitoylation ( Fig. 6A, B ). In summary, our data show that, as with human and mouse IFITM3, 311 microbat IFITM3 can be S-palmitoylated on each of the three cysteine residues, with C72 being the preferred site. Furthermore, mbIFITM3 P70W showed a comparable reduction in S-palmitoylation 313 to the single cysteine mutants of mbIFITM3.
315
Palmitoylation defective cysteine mutants of mbIFITM3 phenocopy the P70W mutation 316 We next studied the ability of the mbIFITM3 S-palmitoylation defective cysteine mutants to restrict 317 viral entry. The infectivity of ZIKV, SFV and virus pseudotypes expressing the envelope proteins of 318 the lyssaviruses West Caucasian Bat Virus (WCBV) and Lagos Bat Virus (LBV) was tested in cells 319 expressing either wt mbIFITM3, mbIFITM3 P70W or the cysteine mutants of mbIFITM3 ( Fig. 7) . All 320 cysteine mutants showed impaired restriction relative to wt mbIFITM3, with a predominant pattern 321 of greatest restriction by C71A > C105A > P70W > C72A. The double (C71A-C72A) and triple (C71A-322 C72A-C105A) mutants showed no restriction relative to control cells. This is consistent with S-323 palmitoylation being greatest for C71A and abrogated for the triple cysteine mutant ( Fig. 6 ),
324
indicating that palmitoylation positively regulates the antiviral activity of mbIFITM3. For 325 comparison, wt huIFITM3 and huIFITM3 P70W were also tested in lyssavirus entry assays. As seen 326 earlier for ZIKV, SFV and IAV, the huIFITM3 P70W protein restricted lyssavirus entry as potently as 327 wt huIFITM3 ( Fig. 7C, D) .
329
Immunofluorescence analysis was performed on stable A549 cells expressing the HA-tagged 330 versions of the different mbIFITM3 cysteine mutants. All single Cys mutants, as well as the double 331 and triple mutants showed preferential perinuclear localization and a reduction in the more widely 332 distributed punctate localization characteristic of wt mbIFITM3 (Fig. 8A, permeabilized) . The 333 intracellular redistribution correlated with reduced exposure of IFITM3 at the cell surface ( Fig. 8A,   334 intact). This was most marked for the double and triple cysteine mutants, which localized almost 335 entirely to perinuclear sites and showed minimal cell surface staining above the background of 336 untransduced cells. Of the mbIFITM3 point mutants, C72A had the most extensive perinuclear 337 localization, correlating with it showing the greatest loss of restriction (Fig. 7) . The perinuclear 338 expression of the P70W mutant was as prominent as that seen for C105A and C71A, but for all three 339 a proportion of cells expressed some IFITM3 at the cell surface and more widely within the cells (Fig.   340 8). As seen for mbIFITM3 P70W, the perinuclear IFITM3 co-localized with the cis Golgi marker 341 Giantin ( Fig. 8B ) and with the trans Golgi network marker TGN46 (Fig. S2B ).
343
In sum, our results show that S-palmitoylation is necessary for viral restriction by microbat IFITM3 344 and that when S-palmitoylation is reduced, either directly by targeted cysteine mutation or 345 indirectly via the P70W mutation, reduced restriction occurs concomitantly with IFITM3 localization to perinuclear, Golgi-associated sites. Our data also indicate that, for mbIFITM3 at least, defective We previously showed that microbat IFITM3 is expressed constitutively in primary cells, as reported 375 for IFITM3 orthologues in other species [33, 34, 41, 69, 70] , as well as induced by a dsRNA PAMP [39] .
376
It has been suggested that basal activation of the Codon 70 is especially diverse across the phylogeny of 31 mammalian IFITMs and lies within the 386 highly conserved IFITM CD225 domain adjacent to known functionally important residues C71/C72.
387
We therefore chose to investigate the effects of amino acid diversity at this site and, to do so, 388 substituted P70 in human IFITM3 with each of the other residues which occur naturally in functional 389 mammalian IFITMs (A, T, G, W, F, V). None of these mutants differed from wt in restricting three 390 different viruses IAV, SFV and ZIKV. An earlier report also showed that substituting P70 of human 391 IFITM3 with T, the residue present in human IFITM2, did not alter IAV restriction or subcellular 392 localization [23] . Our study isolated the effects of six different codon 70 residues within the 393 background of human IFITM3, but does not exclude the possibility that these residues might have 394 functional consequences in the context of different IFITMs or against other viruses. were plated for infection in 96-well CellCarrier Ultra plates (Perkin Elmer). Fixation and staining 575 conditions were as described for flow cytometry, but with nuclei stained with 5 μg/mL Hoechst-576 33258 (Sigma). Imaging was done on an Opera LX system (Perkin Elmer). For each well, three 577 images were acquired using a 4x objective (together accounting for one third of the total well area). Immunofluorescence on saponin-permeabilized cells was carried out as described previously [5] 593 except that cells were fixed in methanol-free 4% (w/v) paraformaldehyde (PFA, Alfa Aesar) in 594 phosphate buffered saline (PBS). This same procedure was followed for intact cells except saponin 595 was omitted from the permeabilization buffer. For live cell staining, cells cultured on coverslips 596 were incubated in media containing primary antibody for 1 h at 37 0 C with 5% CO 2 . The cells were 597 washed twice in media and once in PBS to remove unbound antibody, then fixed and either 598 permeabilized or left intact and processed as described above. Rat anti-HA primary antibody (clone 599 3F10, Roche, 1:100) was detected with either goat anti-rat conjugated to Alexa Fluor (AF) 488
600
(1:500) or with donkey anti-rat AF 488 (1:500). Rabbit anti-giantin primary antibody (Abcam, 601 discontinued, 1:1000) was detected with goat anti-rabbit AF 647 and sheep anti-TGN46 primary 602 antibody (Biorad, AHP500, 1:100) was detected with donkey anti-goat AF 647 (1:500). temperature. Proteins were then precipitated with 2 volumes methanol, 0.5 volume chloroform and 614 1 volume water. The protein pellet was washed twice with methanol before boiling in 1X non-615 reducing loading buffer for 5 min and loading onto a 4-15% TGX stain-free gel (Bio-Rad 4568085).
616
Following SDS-PAGE, gels were visualised using a Typhoon FLA 9500 imager (GE Healthcare, 617 excitation laser: 532nm, emission filter: LPG (575-700nm)) to detect TAMRA (i.e. proteins labeled by the click reaction) and Cy5 (for MW markers). Proteins were then transferred onto PVDF for western 619 blotting using anti-HA (Abcam, ab18181, 1:1000) and anti-HSP90 (Santa Cruz Biotechnology, sc-620 69703). Densitometric quantification of TAMRA fluorescence (from Typhoon images) and HA 621 (following ECL) was performed on 16-bit images using Image J 1.47v. 0.02% bromophenol blue), heated for 5 min at 95 o C and allowed to cool for 30 min. 6 µl (=10 µg) 634 total protein was then reacted with streptavidin (Sigma, S4762) in PBS (total reaction volume 24 µl) 635 for 5 min at RT. Assuming that IFITM3 comprised all of the total protein, streptavidin was used at a 636 0.5X molar excess and titrations showed streptavidin was non-limiting at this amount (Fig. S3B ).
637
Samples were then run on 4-15% TGX SDS-PAGE gels, with cooling packs to ensure heat 638 generation did not disrupt the biotin-streptavidin interaction. Proteins were transferred to PVDF 639 membranes, blocked in 5% bovine serum albumin (BSA) and then blotted using anti-HA (Abcam 640 ab18181, 1:1000 in 0.5% BSA). Following ECL detection of HA, membranes were washed in TBS-T, 641 blocked again in 5% BSA overnight and re-blotted using anti-actin (Abcam ab6276, 1:1000 in 0.5% 642 BSA) to provide a loading control. Image J was used to quantitate HA signal density from ECL 643 images using lane intensity plots. The proportion of total IFITM3 that was palmitoylated (and 644 therefore shifted by streptavidin binding to biotin-modified IFITM3-HA) was calculated as (HA 
